Concepedia

Author

Santiago Moreno

Hospital Universitario Ramón y CajalORCID

Also Known As

A Inciarta, A Moreno Zamora, A.M. Moreno Zamora, Alberto Moreno, Alejandra Gimeno, Ana Barrios, Ana Moreno Zamora, Antinori, Andrea, Bonnet, Fabrice, C Moreno

916

Publications

23.1K

Citations

75

H-Index

235

Concepts

All Affiliations

Hospital Universitario Ramón y CajalInstituto Ramón y Cajal de Investigación SanitariaInstituto CajalUniversidad de AlcaláHospital General Universitario Gregorio Marañón
SM

About

Santiago Moreno is an author at Hospital Universitario Ramón y Cajal specializing in medicine, hiv, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

44

116

5.3K

2

Public Health

18

26

988

3

Health Sciences

10

10

564

4

Social Sciences

5

5

99

5

Natural Sciences

1

1

31

Santiago Moreno

×

332

Publications

16.5K

Citations

66

H-Index

YearCitations

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

Sergio Serrano‐Villar, Talía Sainz, Sulggi A. Lee,

PLoS Pathogens

2014

599

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel

Vincent Soriano, Mark Sulkowski, Colm Bergin,

AIDS

2002

443

Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus

Juan Berenguer, Santiago Moreno, F Laguna,

New England Journal of Medicine

1992

434

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Amanda Mocroft, Jens Lundgren, Miriam Lewis Sabin,

PLoS Medicine

2013

351

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy

Julia del Amo, Rosa Polo, Santiago Moreno,

Annals of Internal Medicine

2020

336

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco,

The Journal of Infectious Diseases

2014

322

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

Jorge F. Vázquez‐Castellanos, Sergio Serrano‐Villar, Amparo Latorre,

Mucosal Immunology

2014

321

Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study

Luz Martı́n-Carbonero, Yves Benhamou, Massimo Puoti,

Clinical Infectious Diseases

2003

272

Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients

Vicente Pintado, Pablo Martín‐Rabadán, María Luisa Fernández Rivera,

Medicine

2001

226

Linezolid for the treatment of multidrug-resistant tuberculosis

Jesús Fortün, Pilar Martín‐Dávila, Enrique Navas,

Journal of Antimicrobial Chemotherapy

2005

224

Page 1